Methylphenidate For ADHD: 5 Facts On Dosage, Benefits, & Risks
Comprehensive guide to methylphenidate (Concerta, Equasym, Medikinet, Ritalin) for treating ADHD in children and adults.

Methylphenidate is a stimulant medicine used to treat
attention deficit hyperactivity disorder (ADHD)
in children over the age of 6, young people and adults. Methylphenidate is also known as Concerta®, Equasym®, Medikinet®, Xaggitin XL® or Ritalin®. Methylphenidate increases activity in parts of the brain which control attention and behaviour. It helps concentration and reduces impulsive behaviour. Methylphenidate comes as standard tablets, modified-release tablets, modified-release capsules and modified-release mini capsules. Standard-release methylphenidate tablets and capsules come in 5 mg, 10 mg and 20 mg sizes. Modified-release methylphenidate tablets and capsules come in 10 mg, 18 mg, 20 mg, 30 mg, 36 mg, 40 mg, 54 mg and 60 mg sizes.About methylphenidate
Methylphenidate is a
central nervous system stimulant
that primarily works by increasing dopamine levels in the brain, particularly in regions responsible for attention and self-control. This mechanism helps improve focus, reduce hyperactivity, and curb impulsivity in individuals with ADHD. Psychostimulants like methylphenidate are the mainstay of pharmacotherapy for ADHD, showing moderate efficacy against core symptoms with a standardized mean difference (SMD) of 0.49 (95% CI, 0.35–0.64).The medication is available under various brand names including
Concerta
(extended-release tablets),Equasym
andMedikinet
(modified-release capsules), andRitalin
(immediate-release tablets). These formulations allow for once-daily dosing in many cases, helping maintain symptom control throughout the day and minimizing rebound effects.Key facts
- Methylphenidate is used to treat ADHD in children aged 6+, adolescents, and adults.
- It starts working within 1 hour, with peak effects in 1-2 hours for immediate-release forms.
- Common brands: Concerta®, Equasym®, Medikinet®, Ritalin®.
- Treatment usually continues as long as it benefits outweigh risks, often reassessed annually.
- About 70-80% of patients respond positively to methylphenidate.
How does methylphenidate work for ADHD?
Methylphenidate works by blocking the reuptake of
dopamine
andnorepinephrine
into presynaptic neurons, increasing their availability in the synaptic cleft. This enhances signaling in prefrontal cortex areas involved in executive function, attention, and impulse control. Studies show it improves vigilance, divided attention, inhibition, focused attention, and reduces omission/commission errors on continuous performance tests.In ADHD, it addresses core symptoms like inattention and hyperactivity. Meta-analyses confirm moderate effect sizes (SMD ~0.5), comparable to atomoxetine but slightly less than amphetamines. Long-term use (up to 1 year) maintains benefits without tolerance, as shown in the COMPAS trial.
When is methylphenidate used?
Methylphenidate is a first-line treatment for ADHD when symptoms significantly impair daily functioning and non-drug interventions are insufficient. In the UK, it’s offered after behavioral therapy or parental training programs fail.
- Children (6+): For moderate-to-severe ADHD with persistent symptoms.
- Adults: When diagnosed with ADHD, often combined with psychological therapy.
- Not first-line for mild ADHD or if contraindications exist (e.g., tics, anxiety).
In adults, it reduces emotion dysregulation (SMD 0.34) alongside core symptoms.
Dosage
Dosage is individualized, starting low and titrating based on response. ‘Start low, go slow’ applies, but adults may need higher doses (up to 100 mg/day).
| Formulation | Starting Dose | Max Daily Dose |
|---|---|---|
| Immediate-release (Ritalin) | 5-10 mg 1-2x/day (children); 10 mg/day (adults) | 60 mg (children); 100 mg (adults) |
| Modified-release (Concerta) | 18 mg once daily | 72 mg (children); 108 mg (adults) |
| Capsules (Equasym/Medikinet XL) | 10 mg once daily | 60 mg |
Adjust every 1-2 weeks; monitor growth in children. Every 10 mg increase yields ~0.11 SMD improvement.
How to take it
Take with or after food to reduce stomach upset. Swallow whole; do not crush modified-release forms. Timing: mornings for school/work coverage. If appetite loss occurs, give last dose after school. Avoid late doses to prevent insomnia.
- Standard tablets: 30-45 min before meals, 3-4x/day.
- Modified-release: Once daily, mornings.
- Mini capsules: Can sprinkle on food if swallowing difficult.
How long to take it for
Continue if beneficial; annual review recommended. Long-term data (2+ years) shows sustained efficacy and functional improvements (e.g., reduced injuries, better academics). Discontinue if no benefit after titration or side effects dominate.
If you forget a dose
Take as soon as remembered unless near next dose. Never double up. For modified-release, skip if late in day.
If you take too much
Overdose symptoms: agitation, hallucinations, seizures, hypertension. Seek emergency help immediately.
Common questions
- Can you drink alcohol? Limited data; avoid excess as it may worsen side effects.
- Pregnancy? Category C; consult doctor, limited safety data.
- Driving? Improves attention but may cause dizziness—monitor.
Side effects
Most are mild and transient. Common (>1/10): decreased appetite (20%), insomnia, headache.
| Frequency | Side Effects |
|---|---|
| Very Common | Reduced appetite, insomnia. |
| Common | Dry mouth (15%), palpitations (13%), nausea, anxiety, tics worsening. |
| Serious (Rare) | Cardiac events, psychosis, growth suppression (monitor height/BMI). |
Long-term: No major cardiovascular risks in adults at therapeutic doses; growth effects reversible.
Who can and cannot take methylphenidate
Cannot take: Glaucoma, severe depression/psychosis, hyperthyroidism, recent MAOI use, tics/Tourette’s (unless benefits outweigh).
Caution: Heart disease, epilepsy, anxiety, history of substance abuse.
Pregnancy and breastfeeding
Avoid if possible; registry data limited. Breastfeeding: small amounts pass into milk—monitor infant.
Interactions
- MAOIs: Contraindicated (2 weeks gap).
- Antidepressants: May increase side effects.
- Warfarin, phenytoin: Monitor levels.
- Alcohol: Potentiates CNS effects.
Other ADHD medicines
Alternatives: Lisdexamfetamine (first-line adult), atomoxetine, guanfacine. Methylphenidate equals atomoxetine efficacy.
Psychological treatments for ADHD
Combine with CBT, behavioral therapy for best outcomes. MPH + therapy superior to either alone.
Frequently asked questions
Will methylphenidate calm my child down?
Yes, it improves focus and reduces hyperactivity, appearing to ‘calm’ by enhancing control.
Does it change personality?
No, it treats symptoms without altering core personality.
Will my child need it forever?
Many continue into adulthood; reassess periodically.
Can it cause addiction?
Low abuse risk when used as prescribed; monitor in substance abuse history.
Does it affect growth?
Minor, temporary height suppression; monitor BMI/height.
Can adults take it?
Yes, effective and safe for adult ADHD.
Analysing your medicines
Track symptoms, side effects in a diary. Share with doctor for dose adjustments.
Further reading & references
References
- Methylphenidate for attention-deficit/hyperactivity disorder in adults — CNS Drugs (PMC). 2021-09-14. https://pmc.ncbi.nlm.nih.gov/articles/PMC8455398/
- New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder — Frontiers in Psychiatry. 2020-11-27. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.531092/full
- ADHD in Children: Symptoms, Types, and Treatment — Patient.info. Recent. https://patient.info/brain-nerves/attention-deficit-hyperactivity-disorder-adhd
- ADHD in Adults: Symptoms, Causes, and Treatment — Patient.info. Recent. https://patient.info/brain-nerves/adhd-in-adults
- Attention Deficit Hyperactivity Disorder (ADHD) | Doctor — Patient.info. Recent. https://patient.info/doctor/paediatrics/attention-deficit-hyperactivity-disorder-pro
- ADHD and Methylphenidate Use in Children and BMI and Height — JAMA Network Open. 2024. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843415
Read full bio of medha deb
















